Oxeia Biopharmaceuticals
San Diego
About Oxeia Biopharmaceuticals
Oxeia Biopharmaceutical soperates in the healthcare industry focusing on pharmaceutical business. According to the Centers for Disease Control, 2.2 million cases of mild traumatic brain injury (concussions) are seen in US hospital emergency rooms every year. Other estimates suggest 4 – 5 million concussions to be more accurate if unreported events are also considered. Research in the last two decades has increasingly linked concussions to neurodegenerative conditions including dementia, Alzheimer’s disease, and chronic traumatic encephalopathy (CTE).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $310.0K
- Last round: Series Unknown (Oct 2017)
- Website: oxeiabiopharma.com
- Phone: [email protected]
Industries & Categories
Biopharma
Social Profiles
Canonical: https://fsome.com/organization/oxeia-biopharmaceuticals-166147 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.